About US
Contact us
-
BT PUSHES FOR R&D INNOVATION AT BIO-IT WORLD CONFERENCEBT shared its vision of the future of pharma R&D and the application of cloud computing strategies to pharma research at the Bio-IT World Conference & Expo held this week in Boston. This visio2011/4/20
-
American Regent Recalls Multiple Productsof Shirley, N.Y. announced voluntary recalls of certain lots of multiple injectable products in March. The recalls include lots of concentrated sodium chloride injection, bacteriostatic sodium chlorid2011/4/19
-
EU Recommendation for Lilly and Amylin Diabetes DrugExperimental diabetes drug Bydureon, developed by Eli Lilly and Amylin Pharmaceuticals, has been recommended for approval by the European Medicines Agency. Bydureon is a longer-acting version of B2011/4/19
-
Eli Lilly receives FDA complete response letter for liprotamase NDAEli Lilly and Company (NYSE: LLY) has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancreatic2011/4/18
-
Johnson & Johnson provides further details regarding distribution rights for REMICADE, SIMPONIJohnson & Johnson (NYSE: JNJ) provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE® (infliximab) and SIMPONI® (golimumab) in2011/4/18
-
Sanofi Reports Positive Results from Diabetes Drug StudySanofi-Aventis has reported positive results from the Phase III study evaluating lixisenatide, a once-daily GLP-1 receptor agonist under development for people with type 2 diabetes. The study achi2011/4/18
-
UK Pharma Companies to Feel the Pressure of NHS Red ListsThe UK National Health Service's decision to prevent family doctors from prescribing drugs will have a negative impact on the pharmaceutical industry, a health expert has warned. Janet Knowles, par2011/4/15
-
PDA/EMA - Joint Conference - Regulation, Cooperation, InnovationOverview Dear Colleagues, PDA and the European Medicine Agency welcome you to the 2011 PDA-EMA Conference in London. Planning for this year’s conference, the fourth in this series, started in May2011/4/15
-
Patients with breast cancer can benefit from new nanobodiesA new discovery published online in The FASEB Journal (http://www.fasebj.org) promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, c2011/4/14
-
Merck and Sun Pharma Announce Joint VentureUS drug manufacturer Merck has formed a joint venture with India-based Sun Pharmaceutical in order to bring innovative formulations to emerging markets. The joint venture plans to developed innova2011/4/14